165 related articles for article (PubMed ID: 12077093)
21. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations.
Monnet E; Faivre J; Raymond L; Garau I
Br J Cancer; 1999 Oct; 81(3):463-8. PubMed ID: 10507771
[TBL] [Abstract][Full Text] [Related]
22. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials.
Batra A; Kong S; Cheung WY
Clin Colorectal Cancer; 2020 Dec; 19(4):e226-e234. PubMed ID: 32636076
[TBL] [Abstract][Full Text] [Related]
23. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
[TBL] [Abstract][Full Text] [Related]
24. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
[TBL] [Abstract][Full Text] [Related]
25. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.
Kneuertz PJ; Chang GJ; Hu CY; Rodriguez-Bigas MA; Eng C; Vilar E; Skibber JM; Feig BW; Cormier JN; You YN
JAMA Surg; 2015 May; 150(5):402-9. PubMed ID: 25806815
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
[TBL] [Abstract][Full Text] [Related]
27. [Cancers of the rectum and colon in the Côte-d'Or department: treatment, prognosis].
Hillon P; Faivre J; Milan C; Bedenne L; Piard F; Klepping C
Gastroenterol Clin Biol; 1985 Oct; 9(10):704-11. PubMed ID: 4065494
[TBL] [Abstract][Full Text] [Related]
28. [Treatment and prognosis of stomach cancers in the population of the Cote d'Or's District (1976-1985)].
Arveux P; Piard F; Bedenne L; Boutron MC; Renard P; Faivre J; Klepping C
Bull Cancer; 1990; 77(8):769-79. PubMed ID: 2207366
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors.
Dabakuyo TS; Dialla O; Gentil J; Poillot ML; Roignot P; Cuisenier J; Arveux P
Eur J Cancer Care (Engl); 2012 Nov; 21(6):809-16. PubMed ID: 22642448
[TBL] [Abstract][Full Text] [Related]
30. Population-based study of diagnosis, treatment and prognosis of gastric cancer.
Msika S; Tazi MA; Benhamiche AM; Couillault C; Harb M; Faivre J
Br J Surg; 1997 Oct; 84(10):1474-8. PubMed ID: 9361617
[TBL] [Abstract][Full Text] [Related]
31. [Colorectal cancer in the Department of Côte-d'Or].
Faivre J; Milan C; Munschi P; Hillon P; Boutron MC; Klepping C
Bull Cancer; 1984; 71(1):50-6. PubMed ID: 6713114
[TBL] [Abstract][Full Text] [Related]
32. Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.
Lièvre A; Laurent V; Cudennec T; Peschaud F; Malafosse R; Benoist S; Penna C; Lepère C; Vaillant JN; Julié C; Teillet L; Nordlinger B; Rougier P; Mitry E
Dig Liver Dis; 2014 Sep; 46(9):838-45. PubMed ID: 24908573
[TBL] [Abstract][Full Text] [Related]
33. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
[TBL] [Abstract][Full Text] [Related]
35. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
[TBL] [Abstract][Full Text] [Related]
36. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
37. Management and prognosis of colon cancer in patients with intestinal obstruction or peritonitis: a French population-based study.
Borie F; Tretarre B; Marchigiano E; Daurcs JP; Millat B
Med Sci Monit; 2005 Jun; 11(6):CR266-273. PubMed ID: 15917717
[TBL] [Abstract][Full Text] [Related]
38. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
39. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.
Gross CP; Andersen MS; Krumholz HM; McAvay GJ; Proctor D; Tinetti ME
JAMA; 2006 Dec; 296(23):2815-22. PubMed ID: 17179458
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
